Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Documenti analoghi

• Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
  di: Ference, Brian A., et al.
  Pubblicazione: (2017)
• Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
  di: Stroes, Erik S., et al.
  Pubblicazione: (2015)
• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
  di: Nordestgaard, Børge G., et al.
  Pubblicazione: (2013)
• Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
  di: Cuchel, Marina, et al.
  Pubblicazione: (2014)
• Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
  di: Orringer, Carl E., et al.
  Pubblicazione: (2020)